Switching from cigarettes to electronic cigarettes may not preserve all the health gains associated with quitting tobacco completely. A study covering more than 4.5 million people found a higher lung-cancer risk among those who took up e-cigarettes than among former smokers who stopped without vaping. The finding adds scale to a question often reduced to an all-or-nothing argument.
The comparison is between different paths after smoking, not a claim that vaping and combustible cigarettes carry identical risks.
The study followed more than 4.5 million people
A Nature research highlight reports that the large study compared health outcomes across smoking and e-cigarette histories. Its central result was that lung-cancer risk was higher among people who began using e-cigarettes after conventional smoking than among people who quit smoking completely.
A cohort that large can detect uncommon outcomes and examine subgroups that smaller studies cannot. Size does not remove every source of bias, however. Participants choose whether to smoke, vape or quit, and those choices may travel with age, health, income, duration of smoking and medical follow-up.
Quitting completely remained the cleaner comparison
Electronic cigarettes can help some smokers move away from burning tobacco, which exposes the lungs to a complex mixture of combustion products. The new result asks a narrower question: whether continuing nicotine use through an aerosol device leaves more risk than ending both exposures.
That distinction matters for public messaging. A person unable to stop smoking may face a different immediate choice from a former smoker considering whether to begin vaping. The study does not support treating every scenario as medically equivalent.
Aerosol is not only water vapor
E-cigarette devices heat a liquid that commonly contains nicotine, flavorings and other chemicals. The resulting aerosol can include fine particles and substances formed during heating. Products differ in power, liquid composition and user behavior, making one exposure category internally diverse.
Cigarette history also matters because lung-cancer risk can remain elevated long after quitting. Researchers must account for years smoked, intensity and time since cessation when estimating what additional risk may be associated with vaping.
Observational evidence has limits
The study identified an association rather than assigning participants randomly to vape or abstain. That design is appropriate for following real-world behavior but cannot eliminate every difference between the groups. Misreported smoking status or changes during follow-up can also blur categories.
Cautious wording matters because the evidence does not prove that vaping erased every benefit of quitting cigarettes. The result instead indicates that former smokers who vaped did not show the same risk profile as those who quit completely in the studied population.
The result changes the harm-reduction conversation
Harm reduction compares realistic alternatives rather than an ideal behavior with no context. Moving fully away from combustible cigarettes may reduce exposure to many toxic products, while remaining on e-cigarettes can preserve nicotine dependence and introduce a different aerosol exposure.
Medical guidance depends on current smoking, prior quit attempts, pregnancy, age and other health conditions. The study strengthens the reason for former smokers to discuss complete nicotine cessation with a clinician while avoiding a return to combustible tobacco.
The most defensible conclusion is also the most practical: stopping cigarettes is not the endpoint of the health question if vaping continues. The 4.5-million-person study suggests that complete cessation and switching should be evaluated as different outcomes, with further research needed to separate long-term device effects from prior tobacco damage.
Exposure classification is difficult when devices and habits change. Some participants may use cigarettes and e-cigarettes together, switch back and forth, or understate occasional smoking. Analyses that separate exclusive use from dual use help prevent a mixed category from obscuring the main comparison.
Lung cancer develops over years, so follow-up length and the timing of the last cigarette matter. A former smoker who starts vaping shortly after quitting has a different exposure history from someone who begins years later. Long-term studies need enough time to distinguish those patterns.
The result also does not evaluate every vaping-related outcome. Respiratory symptoms, cardiovascular effects, nicotine dependence and cancer can follow different timelines. A finding centered on lung-cancer risk should not be stretched into a complete ranking of all possible harms.
Nicotine dependence can keep former smokers attached to a daily inhalation routine even after cigarettes stop. Flavor, device convenience and changing nicotine concentration influence use, so researchers need more than a yes-or-no vaping question to estimate dose.
Complete cessation may be difficult, and relapse to smoking remains a serious concern. Clinical support can include counseling and approved medications, allowing the goal of ending nicotine use to be pursued without framing a setback as failure or encouraging a return to cigarettes.
Future work can compare device generation, nicotine level and years of use rather than placing every e-cigarette in one category. Heating temperature and liquid composition have changed rapidly, so a cohort dominated by older devices may not describe exposure from newer products exactly.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- Scientists spotted a rare tusked whale alive at sea for the first time, then fired a crossbow at it.
- A Colorado wildfire forced level-three ‘leave now’ orders across Ouray County
- A skeleton beneath Petra’s Treasury was found clutching a chalice that resembles the Holy Grail
- 8 SUVs mechanics are quietly steering buyers away from in 2026
